TECH
Bio-Techne·NASDAQ
--
--(--)
Market Open: --
--
--(--)
Pre-Market: --
Signals Analysis
Bullish signal 4
Bearish signal 2
Consensus Rating "Buy"
Ample Liquidity
High Gross Profit Margin
Significant Net Income Decline
High Cash/net Profit Ratio
EPS Below Expectations
Key Stats
0.0000DAY`S RANGE0.0000
0.000052 WK RANGE0.0000
0.0000
0.0000
--
--
--
--
--
--
--
--
--
--
--
--
--
--
0.0000
0.0000
0.0000
0.0000
About TECH
Bio-Techne Corporation
A leading developer and manufacturer of biotechnology reagents and instruments for research, diagnostics, and pharmaceutical applications
Life Science Tools and Services
07/17/1981
05/12/1989
NASDAQ Stock Exchange
3,100
06-30
Common stock
614 McKinley Place N.E., Minneapolis, MN 55413
--
Bio-Techne Corporation was founded in Minnesota on July 17, 1981. Bio-Techne and its subsidiaries jointly operate businesses that develop, manufacture and sell life science reagents, instruments and services for the global research, diagnostic and bioprocessing markets. With its deep product portfolio and applied expertise, the company sells components of scientific investigations of biological processes and molecular diagnosis, revealing the nature, diagnosis, etiology and progression of specific diseases.
Earnings Call
Q3/2025
Estimate EPS0.51
Actual EPS0.56
Estimate Revenue317.33M
Actual Revenue316.18M
Bio-Techne's Q3 2025 Earnings Call: Unpacking Contradictions on Tariffs, Academic Revenue, and Segment Growth
May 07,2025 07:22
Earnings Decrypt
Earnings Decrypt
Q4/2025
Estimate EPS0.5
Actual EPS0.53
Estimate Revenue314.70M
Actual Revenue317.00M
Bio-Techne's Q4 2025: Navigating Contradictions in NIH Funding, China Growth, and Revenue Outlook
Aug 13,2025 05:45
Earnings Decrypt
Earnings Decrypt
Company Financials
EPS
TECH has released its 2026 Q1 earnings. EPS was reported at 0.42, versus the expected 0.42, meeting expectations. The chart below visualizes how TECH has performed over recent quarters, highlighting trends in earnings surprises.
Revenue & Expenses
TECH has released its 2026 Q1 earnings report, with revenue of 286.56M, reflecting a YoY change of -1.00%, and net profit of 38.19M, showing a YoY change of 13.65%. The Sankey diagram below clearly presents TECH's revenue sources and cost distribution.
Forecast
Wall Street Opinions
Price Target
Volume Profile
Trade Flow Insight
Seasonals
Community Forum
Loading...
Related News
No articles available
